Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
PSNL
PSNL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PSNL News
Personalis Gains 10% After Medicare Coverage for NeXT Personal Test
5d ago
seekingalpha
Personalis Secures Medicare Coverage, Stock Rises
5d ago
Benzinga
Medicare Expands Coverage for NeXT Personal Lung Cancer Test
5d ago
stocktwits
Personalis Secures Medicare Coverage for Lung Cancer Monitoring
5d ago
Newsfilter
AIGH Capital Fully Exits Lumen Technologies Stake
Feb 03 2026
Fool
Personalis Unveils New Study Highlighting MRD Assay Potential in Immunotherapy Monitoring
Feb 02 2026
Newsfilter
Personalis to Attend BTIG MedTech Conference
Jan 28 2026
Yahoo Finance
ARK Invest Deepens AI Chip and Gene Editing Investments, Sells 86K Tesla Shares
Jan 19 2026
seekingalpha
ARK Invest Focuses on Innovation Themes, Increases Stake in Komatsu and Others
Jan 12 2026
seekingalpha
ARK Genomic Revolution ETF Falls 2.5%, Personalis Drops 9.8%
Jan 08 2026
NASDAQ.COM
Oncolytics Biotech Achieves 33% Response Rate with Pelareorep in KRAS-Mutant Colorectal Cancer
Dec 31 2025
Newsfilter
Oncolytics Biotech Reports 33% Response Rate in KRAS-Mutant Colorectal Cancer with Pelareorep
Dec 31 2025
PRnewswire
Personalis Publishes ctDNA Study Showing 98% Detection Rate in Patients
Dec 17 2025
Newsfilter
Personalis Publishes TRACERx Study with 431 NSCLC Patients, Enhancing Early Detection Capabilities
Dec 11 2025
Newsfilter
Morgan Stanley Keeps Equal-Weight Rating on Personalis and Increases Price Target to $9
Nov 11 2025
Benzinga
BTIG Reaffirms Buy Rating on Personalis, Increases Price Target to $12
Nov 11 2025
Benzinga
Show More News
